Immune globulin (CSL Behring)

N/A

Report date: 2024/01/23 10:54:09

Base Information

Drug NameImmune globulin (CSL Behring)
Drug Alias NameIVIG-10%-CSL BehringRedimune NF liquidSandoglobulin NF liquidRhesogamma PIgNextGen 10% +[18] 
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationX chain low immunoglobulinIschemic Stroke +[28] 
Global Approved IndicationsImmunologic Deficiency SyndromesAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2008/04/24
Country/TerritoryCzechiaBelgiumCanada +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring KkCsl BehringCsl Behring Gmbh +[7] 
Inactive CompaniesCsl LtdAarhus UniversitySaint Louis University +[6] 
Active IndicationsMental DisordersImmunologic Deficiency SyndromesScleroderma, Diffuse +[11] 
Inactive IndicationsRejection of renal transplantationX chain low immunoglobulinIschemic Stroke +[17] 

Other Information

ATC CodeJ06BA02
Related LinksN/A